(CGRP) Monocloncal antibodies

• Diagnosis and management of migraine in ten steps

  2021 Nature Reviews Neurology review Medicine Migraine and Headache Studies Open access cited by 1 patent

  594

  citations
• European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

  2022 The Journal of Headache and Pain article Medicine Migraine and Headache Studies Open access

  407

  citations
• Medication overuse headache

  2023 Nature Reviews Disease Primers review Medicine Migraine and Headache Studies

  212

  citations
• Anti‐migraine Calcitonin Gene–Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice

  2020 Annals of Neurology article Medicine Migraine and Headache Studies Open access

  121

  citations
• Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies

  2022 Neurology article Medicine Migraine and Headache Studies Open access

  67

  citations
• Long-term Efficacy and Safety of Erenumab

  2021 Neurology article Medicine Migraine and Headache Studies Open access

  49

  citations
• The potential danger of blocking CGRP for treating migraine in CADASIL patients

  2020 Cephalalgia article Medicine Migraine and Headache Studies Open access

  24

  citations
• Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study

  2023 Frontiers in Neurology article Medicine Migraine and Headache Studies Open access

  15

  citations

8 results